Check product status
Real medicines exist.
The name matters.
Ask about the exact injection. Approval for a drug does not settle the status of every product offered under its name.
The Food and Drug Administration reviews drugs in the US; its short name is FDA.
Which named injections have approval?
Approved injections
A named product and use.
As of September 2026, approved semaglutide injections include Ozempic for diabetes care and Wegovy for weight management among their specified uses.
Another approved drug
Uses vary by brand.
As of September 2026, tirzepatide (Mounjaro, Zepbound) has approved injection products; Mounjaro includes diabetes care and Zepbound includes weight management.
Research peptides
Ask for the approval record.
The FDA application records, as of September 2026, contain no US product approval for BPC-157, ipamorelin, epitalon, MOTS-c or retatrutide.
The weight-treatment term you may see.
The body’s natural GLP-1 signal plays a role in both blood sugar and hunger.
The GLP-1 medicine group includes semaglutide and tirzepatide.
Ask which medicine is proposed, whether it comes as a pill or an injection, and what it is meant to treat.
Compounding does not turn every peptide into an option.
As of September 2026, FDA says that using retatrutide or cagrilintide in compounding is prohibited by federal law.
Neither semaglutide nor tirzepatide has an approved, marketable US generic as of September 2026.
A compounded product is not an FDA-approved generic version of an approved drug.
A drug code does not prove approval.
As of September 2026, a product may have a National Drug Code, or NDC, in the FDA’s online drug list without being FDA-approved.
Someone may show you this code on a label or website. Request the named medicine’s approval record; the code alone does not answer that question.